Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Jun 2020

May Shoshanna, Adamska Ewelina, Tang Julian

Abstract excerpt

BACKGROUND: Antiretroviral drug resistance testing is an integral part of the management of patients infected with HIV. The traditional Sanger sequencing method is capable of detecting drug resistant mutations (DRMs) that make up at least 10-15% of the viral quasispecies population. Newer next generation sequencing technologies have a greater sensitivity for the detection of minority variant DRMs down to around...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Automation, Laboratory

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Genotyping Techniques

Share to HIV Infections

Share to Reproducibility of Results

Share to Viral Load

Source

Identifiers

PMID: 32344322
DOI: 10.1016/j.jcv.2020.104376

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Vela Diagnostics HIV-1 genotyping assay on an automated next generation sequencing platform.PMID 32344322Read ↗

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.Semantic proximity Read ↗

Performance evaluation of the Vela Dx Sentosa next-generation sequencing system for HIV-1 DNA genotypic resistance.Semantic proximity Read ↗

HIV-1 Drug Resistance Assay Using Ion Torrent Next Generation Sequencing and On-Instrument End-to-End Analysis Software.Semantic proximity Read ↗

Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance TestingSemantic proximity Read ↗

Analytical Assessment of the Vela Diagnostics NGS Assay for HIV Genotyping and Resistance Testing: The Apulian Experience.Semantic proximity Read ↗

Performance of a high-throughput next-generation sequencing method for analysis of HIV drug resistance and viral load.Semantic proximity Read ↗

Technologies for HIV-1 drug resistance testing: inventory and needs.Semantic proximity Read ↗

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.Semantic proximity Read ↗

A new sensitive and robust next-generation sequencing platform for HIV-1 drug resistance mutations testingSemantic proximity Read ↗

Next-Generation Sequencing for HIV Drug Resistance Testing: Laboratory, Clinical, and Implementation Considerations.Semantic proximity Read ↗

Evaluation of a HIV-1 drug resistance genotyping method based on high-throughput sequencing (HTS).Semantic proximity Read ↗

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited SettingsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.